Stock DNA
Pharmaceuticals & Biotechnology
HKD 190,380 Million ()
NA (Loss Making)
NA
0.00%
-0.85
-999,999.00%
3.00
Revenue and Profits:
Net Sales:
4 Million
(Quarterly Results - Sep 2017)
Net Profit:
-1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-13.84%
0%
-13.84%
6 Months
43.8%
0%
43.8%
1 Year
95.58%
0%
95.58%
2 Years
62.81%
0%
62.81%
3 Years
-25.78%
0%
-25.78%
4 Years
-15.37%
0%
-15.37%
5 Years
-51.02%
0%
-51.02%
JD Health International, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
25.17%
EBIT Growth (5y)
12.09%
EBIT to Interest (avg)
-5.66
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.93
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.16
EV to EBIT
-80977.40
EV to EBITDA
-95113.88
EV to Capital Employed
11.62
EV to Sales
9650.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.01%
ROE (Latest)
-0.00%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'17 - YoY
Sep'17
Sep'16
Change(%)
Net Sales
4.00
3.20
25.00%
Operating Profit (PBDIT) excl Other Income
-0.20
-0.80
75.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.60
-0.90
33.33%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2017 is 25.00% vs 28.00% in Sep 2016
Consolidated Net Profit
YoY Growth in quarter ended Sep 2017 is 33.33% vs 47.06% in Sep 2016
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
59,150.50
54,348.40
8.84%
Operating Profit (PBDIT) excl Other Income
948.40
-5.20
18,338.46%
Interest
10.50
10.60
-0.94%
Exceptional Items
0.00
0.00
Consolidate Net Profit
2,367.90
445.60
431.40%
Operating Profit Margin (Excl OI)
11.80%
-3.10%
1.49%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 8.84% vs 46.97% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 431.40% vs 134.46% in Dec 2022
About JD Health International, Inc. 
JD Health International, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






